FDA lays out plans for a new review framework for AI and machine learning-based devices
Apr 3, 2019 @ 10:56

The FDA has begun to reconsider how it reviews and approves medical devices that employ artificial intelligence and to learn from data to adapt their care.

Sourced through Scoop.it from: www.fiercebiotech.com

Leave a Reply